{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:56:33Z","timestamp":1780077393579,"version":"3.54.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"R\u00e9seau SIDA et Maladies Infectieuses du Fonds de la Recherche du Qu\u00e9bec \u2013 Sant\u00e9"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.drugpo.2017.05.027","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T23:17:34Z","timestamp":1498605454000},"page":"61-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["High hepatitis C incidence in relation to prescription opioid injection and poly-drug use: Assessing barriers to hepatitis C prevention"],"prefix":"10.1016","volume":"47","author":[{"given":"Svetlana","family":"Puzhko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9lise","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Jutras-Aswad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea Adelina","family":"Artenie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3933-2996","authenticated-orcid":false,"given":"Emmanuel","family":"Fortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bruneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugpo.2017.05.027_bib0005","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1196\/annals.1369.044","article-title":"Comparison between heroin and heroin-cocaine polyabusers: A psychopathological study","volume":"1074","author":"Bandettini Di Poggio","year":"2006","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.027_bib0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1176\/appi.ajp.2015.15020262","article-title":"Prescription opioid misuse, abuse, and treatment in the United States: An update","volume":"173","author":"Brady","year":"2016","journal-title":"American Journal of Psychiatry"},{"issue":"7","key":"10.1016\/j.drugpo.2017.05.027_bib0015","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1360-0443.2012.03803.x","article-title":"The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users","volume":"107","author":"Bruneau","year":"2012","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.drugpo.2017.05.027_bib0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0376-8716(98)00028-3","article-title":"Self-report among injecting drug users: A review","volume":"51","author":"Darke","year":"1998","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.drugpo.2017.05.027_bib0025","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/add.13158","article-title":"Which medications are suitable for agonist drug maintenance?","volume":"111","author":"Darke","year":"2016","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.027_bib0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0376-8716(02)00019-4","article-title":"Cocaine use in New South Wales, Australia, 1996\u20132000: 5 year monitoring of trends in price, purity, availability and use from the illicit drug reporting system","volume":"67","author":"Darke","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.drugpo.2017.05.027_bib0035","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/QAI.0b013e3181565dde","article-title":"Rethinking approaches to risk reduction for injection drug users: Differences in drug type affect risk for HIV and hepatitis C virus infection through drug-injecting networks","volume":"46","author":"De","year":"2007","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"11","key":"10.1016\/j.drugpo.2017.05.027_bib0040","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1111\/j.1360-0443.2005.01271.x","article-title":"Harm reduction interventions, behaviours and associated health outcomes in France, 1996\u20132003","volume":"100","author":"Emmanuelli","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2017.05.027_bib0045","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1477-7517-5-30","article-title":"A qualitative exploration of prescription opioid injection among street-based drug users in Toronto: Behaviours, preferences and drug availability","volume":"5","author":"Firestone","year":"2008","journal-title":"Harm Reduction Journal"},{"issue":"Suppl. 3","key":"10.1016\/j.drugpo.2017.05.027_bib0050","doi-asserted-by":"crossref","first-page":"Es191","DOI":"10.36076\/ppj.2012\/15\/ES191","article-title":"Prescription opioid related misuse, harms, diversion and interventions in Canada: A review","volume":"15","author":"Fischer","year":"2012","journal-title":"Pain Physician"},{"key":"10.1016\/j.drugpo.2017.05.027_bib0055","series-title":"Offene Grenzen der Substitution","first-page":"95","article-title":"The phenomenon of so-called \u2018other drug use\u2019 among opiate addicts in the North American context: Evidence, consequences, questions","author":"Fischer","year":"2000"},{"key":"10.1016\/j.drugpo.2017.05.027_bib0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13011-016-0055-4","article-title":"Treatment of prescription opioid disorders in Canada: Looking at the \u2018other epidemic\u2019?","volume":"11","author":"Fischer","year":"2016","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"10","key":"10.1016\/j.drugpo.2017.05.027_bib0065","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/MLR.0000000000000625","article-title":"The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013","volume":"54","author":"Florence","year":"2016","journal-title":"Medical Care"},{"issue":"14","key":"10.1016\/j.drugpo.2017.05.027_bib0070","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1157\/13093723","article-title":"Factors associated with sharing syringes among street-recruited injecting drug users","volume":"127","author":"Folch","year":"2006","journal-title":"Medicina Clinica (Barcelona)"},{"issue":"9","key":"10.1016\/j.drugpo.2017.05.027_bib0075","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/add.12598","article-title":"The burden of premature opioid-related mortality","volume":"109","author":"Gomes","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2017.05.027_bib0080","first-page":"Cd004145","article-title":"Substitution treatment of injecting opioid users for prevention of HIV infection","volume":"4","author":"Gowing","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1016\/j.drugpo.2017.05.027_bib0085","doi-asserted-by":"crossref","first-page":"e005419","DOI":"10.1136\/bmjopen-2014-005419","article-title":"Prescription opioid injection and risk of hepatitis C in relation to traditional drugs of misuse in a prospective cohort of street youth","volume":"4","author":"Hadland","year":"2014","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.drugpo.2017.05.027_bib0090","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/01.ede.0000135170.54913.9d","article-title":"Hepatitis C virus infection among injection drug users: Survival analysis of time to seroconversion","volume":"15","author":"Hagan","year":"2004","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.027_bib0095","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2105\/AJPH.91.1.42","article-title":"Sharing of drug preparation equipment as a risk factor for hepatitis C","volume":"91","author":"Hagan","year":"2001","journal-title":"American Journal of Public Health"},{"issue":"3","key":"10.1016\/j.drugpo.2017.05.027_bib0100","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.drugalcdep.2011.10.001","article-title":"Latent classes of heroin and cocaine users predict unique HIV\/HCV risk factors","volume":"122","author":"Harrell","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.027_bib0105","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.2105\/AJPH.2012.300874","article-title":"Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users","volume":"103","author":"Havens","year":"2013","journal-title":"American Journal of Public Health"},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.027_bib0110","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.drugalcdep.2006.07.008","article-title":"Prevalence of opioid analgesic injection among rural nonmedical opioid analgesic users","volume":"87","author":"Havens","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.drugpo.2017.05.027_bib0115","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0376-8716(94)90128-7","article-title":"Applying behavioral concepts and principles to the treatment of cocaine dependence","volume":"34","author":"Higgins","year":"1994","journal-title":"Drug and Alcohol Dependence"},{"issue":"13","key":"10.1016\/j.drugpo.2017.05.027_bib0120","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3109\/10826084.2015.1027928","article-title":"Patterns of, and factors associated with, illicit pharmaceutical opioid analgesic use in a prospective cohort of people who inject drugs in Melbourne, Australia","volume":"50","author":"Horyniak","year":"2015","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.drugpo.2017.05.027_bib0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1477-7517-10-11","article-title":"Establishing the Melbourne Injecting Drug User Cohort Study (MIX): Rationale, methods, and baseline and twelve-month follow-up results","volume":"10","author":"Horyniak","year":"2013","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.drugpo.2017.05.027_bib0130","unstructured":"International Narcotics Control Board. (2012). Narcotic drugs technical report: Estimated world requirements for 2012. Retrieved 15th May 2015 from.https:\/\/www.incb.org\/documents\/Narcotic-Drugs\/Technical-Publications\/2012\/NDR_2012_Part2_Comments_E.pdf."},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.027_bib0135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: A review of opioid and benzodiazepine combination use","volume":"125","author":"Jones","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.drugpo.2017.05.027_bib0140","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-2893.2005.00643.x","article-title":"Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: Cross sectional analysis","volume":"12","author":"Judd","year":"2005","journal-title":"Journal of Viral Hepatitis"},{"issue":"9","key":"10.1016\/j.drugpo.2017.05.027_bib0145","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.addbeh.2014.04.020","article-title":"Injection and non-injection drug use and infectious disease in Baltimore city: Differences by race","volume":"39","author":"Keen","year":"2014","journal-title":"Addictive Behaviors"},{"issue":"6","key":"10.1016\/j.drugpo.2017.05.027_bib0150","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s11524-012-9691-9","article-title":"Patterns of prescription drug misuse among young injection drug users","volume":"89","author":"Lankenau","year":"2012","journal-title":"Journal of Urban Health"},{"issue":"9","key":"10.1016\/j.drugpo.2017.05.027_bib0155","doi-asserted-by":"crossref","first-page":"e106899","DOI":"10.1371\/journal.pone.0106899","article-title":"Risk behaviors, prevalence of HIV and hepatitis C virus infection and population size of current injection drug users in a China\u2013Myanmar border city: Results from a respondent-driven sampling survey in 2012","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.drugpo.2017.05.027_bib0160","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.annepidem.2006.10.009","article-title":"Test for additive interaction in proportional hazards models","volume":"17","author":"Li","year":"2007","journal-title":"Annals of Epidemiology"},{"issue":"10","key":"10.1016\/j.drugpo.2017.05.027_bib0165","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/add.12643","article-title":"A prospective study of hepatitis C incidence in Australian prisoners","volume":"109","author":"Luciani","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2017.05.027_bib0170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.drugpo.2016.01.022","article-title":"Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities","volume":"31","author":"Marshall","year":"2016","journal-title":"International Journal of Drug Policy"},{"issue":"11","key":"10.1016\/j.drugpo.2017.05.027_bib0175","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.2105\/AJPH.2015.302843","article-title":"Worldwide prevalence and trends in unintentional drug overdose: A systematic review of the literature","volume":"105","author":"Martins","year":"2015","journal-title":"American Journal of Public Health"},{"issue":"3","key":"10.1016\/j.drugpo.2017.05.027_bib0180","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/jhep.2002.35065","article-title":"Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users","volume":"36","author":"Miller","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.drugpo.2017.05.027_bib0185","first-page":"Cd011117","article-title":"Opioid agonist treatment for pharmaceutical opioid dependent people","volume":"5","author":"Nielsen","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1016\/j.drugpo.2017.05.027_bib0190","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/00952997509002733","article-title":"Studying addicts over time: Methodology and preliminary findings","volume":"2","author":"Nurco","year":"1975","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.027_bib0195","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1254\/jphs.08249FP","article-title":"Comparison of five benzodiazepine-receptor agonists on buprenorphine-induced mu-opioid receptor regulation","volume":"110","author":"Poisnel","year":"2009","journal-title":"Journal of Pharmacological Sciences"},{"key":"10.1016\/j.drugpo.2017.05.027_bib0200","series-title":"SAS\/STAT 9.3. User\u2019s guide","author":"Release","year":"2011"},{"issue":"3","key":"10.1016\/j.drugpo.2017.05.027_bib0205","first-page":"e120","article-title":"Social determinants of health associated with hepatitis C co-infection among people living with HIV: Results from the Positive Spaces, Healthy Places study","volume":"5","author":"Rourke","year":"2011","journal-title":"Open Med"},{"issue":"1\u20132","key":"10.1016\/j.drugpo.2017.05.027_bib0210","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugalcdep.2008.03.025","article-title":"Buprenorphine in primary care: Risk factors for treatment injection and implications for clinical management","volume":"97","author":"Roux","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.027_bib0215","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1258\/095646207779949880","article-title":"High hepatitis C virus prevalence and incidence among Canadian intravenous drug users","volume":"18","author":"Roy","year":"2007","journal-title":"International Journal of STD & AIDS"},{"issue":"9","key":"10.1016\/j.drugpo.2017.05.027_bib0220","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3109\/10826084.2011.552932","article-title":"The growing popularity of prescription opioid injection in downtown Montreal: New challenges for harm reduction","volume":"46","author":"Roy","year":"2011","journal-title":"Substance Use & Misuse"},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.027_bib0225","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1465-3362.2011.00299.x","article-title":"Drug use patterns in the presence of crack in downtown Montreal","volume":"31","author":"Roy","year":"2012","journal-title":"Drug and Alcohol Review"},{"issue":"1\u20133","key":"10.1016\/j.drugpo.2017.05.027_bib0230","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2009.01.006","article-title":"Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience","volume":"102","author":"Roy","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.drugpo.2017.05.027_bib0235","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.drugpo.2013.05.005","article-title":"What is low threshold methadone maintenance treatment?","volume":"24","author":"Strike","year":"2013","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2017.05.027_bib0240","unstructured":"Studio, R. (2012). R Studio: Integrated development environment for R: Version 0.97."},{"issue":"11","key":"10.1016\/j.drugpo.2017.05.027_bib0245","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s11064-007-9373-2","article-title":"Autoradiographic analysis of GABAA receptors in mu-opioid receptor knockout mice","volume":"32","author":"Tien","year":"2007","journal-title":"Neurochemical Research"},{"issue":"12","key":"10.1016\/j.drugpo.2017.05.027_bib0250","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1001\/jamainternmed.2014.5416","article-title":"Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users","volume":"174","author":"Tsui","year":"2014","journal-title":"JAMA Internal Medicine"},{"issue":"11","key":"10.1016\/j.drugpo.2017.05.027_bib0255","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/j.1360-0443.2011.03515.x","article-title":"The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: Pooling of UK evidence","volume":"106","author":"Turner","year":"2011","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.drugpo.2017.05.027_bib0260","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/EDE.0b013e31821db503","article-title":"Causal interactions in the proportional hazards model","volume":"22","author":"VanderWeele","year":"2011","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.027_bib0265","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1515\/em-2013-0005","article-title":"A tutorial on interaction","volume":"3","author":"VanderWeele","year":"2014","journal-title":"Epidemiologic Methods"},{"issue":"11","key":"10.1016\/j.drugpo.2017.05.027_bib0270","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1111\/j.1360-0443.2012.03932.x","article-title":"Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings","volume":"107","author":"Vickerman","year":"2012","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.drugpo.2017.05.027_bib0275","doi-asserted-by":"crossref","first-page":"326","DOI":"10.5694\/mja13.00153","article-title":"Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: The HITS-c study","volume":"201","author":"White","year":"2014","journal-title":"Medical Journal of Australia"},{"issue":"11","key":"10.1016\/j.drugpo.2017.05.027_bib0280","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.2105\/AJPH.2014.302142","article-title":"Risk factors for HCV infection among young adults in rural new york who inject prescription opioid analgesics","volume":"104","author":"Zibbell","year":"2014","journal-title":"American Journal of Public Health"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917301317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917301317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T21:36:28Z","timestamp":1656970588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395917301317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":56,"alternative-id":["S0955395917301317"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.05.027","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High hepatitis C incidence in relation to prescription opioid injection and poly-drug use: Assessing barriers to hepatitis C prevention","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}